Skip to main content

Table 1 Baseline characteristics of people living with HIV at the time of starting ART. Data on risk group are available for 170,930 (63.5%) individuals. IDU – intravenous drug user; MSM – men who have sex with men

From: Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006–2015

  Number (%) Deaths (%)
Time on ART
 0–6 months 269,076 (100) 6836 (31)
 7–12 months 259,734 (97) 2062 (9)
 13–24 months 252,929 (94) 3116 (14)
 25–36 months 223,556 (83) 2558 (12)
  > 36 months 185,632 (69) 7177 (33)
Age (years)
 15–24 27,136 (10) 1238 (6)
 25–34 84,444 (31) 5900 (27)
 35–44 83,467 (31) 7285 (33)
  > 45 74,029 (28) 7326 (34)
CD4 cell count (cells per μL)
  < 200 87,765 (33) 13,946 (66)
 200–349 77,229 (29) 4685 (22)
 350–499 49,911 (19) 1750 (8)
  ≥ 500 54,171 (20) 1368 (6)
Sex
 Male 165,643 (62) 14,536 (67)
 Female 103,433 (38) 7213 (33)
Year of ART initiation
 2006 18,056 (7) 2530 (12)
 2007 21,699 (8) 3015 (14)
 2008 33,666 (13) 4068 (19)
 2009 22,111 (8) 2710 (12)
 2010 22,387 (8) 2342 (11)
 2011 22,621 (8) 1967 (9)
 2012 26,968 (10) 1911 (8)
 2013 29,668 (11) 1466 (7)
 2014 35,818 (13) 1092 (5)
 2015 36,082 (13) 648 (3)
Region
 Southeast 129,531 (48) 9868 (45)
 Central-West 17,261 (6) 1450 (7)
 Northeast 41,684 (15) 3327 (15)
 South 62,400 (23) 5633 (26)
 North 18,168 (7) 1469 (7)
 missing 32 (0.01) 2 (0.009)
Risk group
 Heterosexual male 51,069 (19) 5552 (26)
 Bisexual male 11,244 (4) 880 (4)
 MSM 36,198 (13) 1857 (9)
 Male IDU 7393 (3) 1401 (6)
 Female non-IDU 63,143 (23) 4910 (23)
 Female IDU 1665 (0.6) 294 (1)
 other 218 (0.08) 28 (0.1)
 missing 98,146 (36) 6827 (31)
Total 269,076 21,749
  1. The percentages in each subgroup refer to the proportion of individuals in each category of the subgroup. The numbers of individuals by time on treatment however, where individuals contribute to multiple periods of treatment time, begin at the total number at baseline (i.e. 100%) and decrease as individuals die / are censored
\